Lifecore Biomedical Inc (LFCR)
5.87
+0.10
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Lifecore Biomedical Accounts Payable (Quarterly): 22.14M for May 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
May 31, 2023 | 22.10M |
February 28, 2023 | 14.76M |
November 30, 2022 | 27.97M |
August 31, 2022 | 16.37M |
May 31, 2022 | 12.95M |
February 28, 2022 | 20.01M |
November 30, 2021 | 59.10M |
August 31, 2021 | 46.36M |
May 31, 2021 | 16.30M |
February 28, 2021 | 56.32M |
November 30, 2020 | 60.89M |
August 31, 2020 | 50.72M |
May 31, 2020 | 51.65M |
February 29, 2020 | 63.66M |
November 30, 2019 | 47.14M |
August 31, 2019 | 46.16M |
May 31, 2019 | 53.97M |
February 28, 2019 | 46.43M |
November 30, 2018 | 31.72M |
August 31, 2018 | 27.03M |
May 31, 2018 | 34.67M |
February 28, 2018 | 35.24M |
November 30, 2017 | 37.48M |
August 31, 2017 | 26.95M |
May 31, 2017 | 24.53M |
Date | Value |
---|---|
February 28, 2017 | 24.76M |
November 30, 2016 | 25.91M |
August 31, 2016 | 31.61M |
May 31, 2016 | 30.90M |
February 29, 2016 | 25.09M |
November 30, 2015 | 36.92M |
August 31, 2015 | 31.95M |
May 31, 2015 | 35.01M |
February 28, 2015 | 28.31M |
November 30, 2014 | 39.52M |
August 31, 2014 | 37.38M |
May 31, 2014 | 32.12M |
February 28, 2014 | 29.73M |
November 30, 2013 | 34.76M |
August 31, 2013 | 29.38M |
May 31, 2013 | 32.26M |
February 28, 2013 | 27.93M |
November 30, 2012 | 26.37M |
August 31, 2012 | 27.26M |
May 31, 2012 | 23.42M |
February 29, 2012 | 14.67M |
November 30, 2011 | 19.22M |
August 31, 2011 | 18.53M |
May 31, 2011 | 17.05M |
February 28, 2011 | 15.14M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
12.95M
Minimum
May 2022
63.66M
Maximum
Feb 2020
39.20M
Average
46.36M
Median
Aug 2021
Accounts Payable (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 10.52M |
SELLAS Life Sciences Group Inc | 7.407M |
ADMA Biologics Inc | 17.19M |
Relmada Therapeutics Inc | 5.189M |
Jaguar Health Inc | 3.32M |